Cerebral aspergillosis: Long term efficacy and safety of liposomal amphotericin B in kidney transplant

Nephrology Dialysis Transplantation

Volumn 13, Issue 10, 1998, Pages 2659-2661

  Carlini, Antonio ^a   Angelini, Daniella ^a   Burrows, Lewis ^b   De Quirico, Graziella ^a   Antonelli, Alessandro ^a  

^a CAMPO DI MARTE HOSPITAL   (Italy)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

Cerebral aspergillosis; Liposomal amphotericin B; Nefrotoxicity; Renal transplant

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT;

ADULT; ARTICLE; ASPERGILLOSIS; CASE REPORT; CHILL; DRUG EFFICACY; DRUG SAFETY; FEVER; HUMAN; KIDNEY TRANSPLANTATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRAIN ABSCESS; DRUG CARRIERS; FOLLOW-UP STUDIES; HUMANS; KIDNEY TRANSPLANTATION; LIPOSOMES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; SAFETY;

EID: 0031663041     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.10.2659     Document Type: Article

References (15)

1. Warnock DW. Fungal complications of transplantation: diagnosis, treatment and prevention. J Antimicrob Chemother 1995; 36 [Suppl B]: 73-90
2. Sessa A, Meroni M, Battini G, Pitingolo F, Giordano F, Marks M, Casella P. Nosocomial outbreak of Aspergillus fumigatus infection among patients in a renal unit. Nephrol Dial Transplant 1996; 11: 1322-1324
3. Brown R Sjr, Lake JR, Katzman BA, Ascher NL, Somberg KA, Emond JC, Roberts JP. Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Transplantation 1996; 61: 666-669
4. Young RC, Bennett JE. Vogel CL, Carbone PP. De Vita VT. Aspergillosis: The spectrum of the disease in 98 patients. Medicine 1970; 49: 147-172
5. Sawaya BP, Briggs JP. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. J Am Soc Nephrol 1995; 6: 154-164
6. Bernardo JF, Murakami S, Branch RA, Sabra R. Potassium depletion potentiates amphotericin B induced nephrotoxicity to renal tubules. Nephron 1995; 70: 235-241
7. Berenguer J, Munoz P, Parras F, Fernandez-Baca V, Hernandez-Sampelayo T, Bouza E. Treatment of deep mycoses with liposomal amphotericin B. Eur J Clin Microbiol Infect Dis 1994; 13: 504-507
8. Hay RJ. Liposomal amphotericin B, AmBisome. J Infect 1994; 28 [Suppl 1]: 35-43
9. Mannes GP, Van der Bij W, De Boer WJ. Liposomal Amphotericin B in three lung transplant recipients. The Groningen Lung Transplantation Group. J Heart Lung Transplant 1995; 14: 781-784
10. Ringden O, Andstrom E, Remberger M, Svahn BM, Tollemar J. Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin. Bone Marrow Transplant 1994; 14 (suppl 5): S10-14
11. Mills W, Chopra R, Linch DC, Goldstone AH. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single centre experience of 133 episodes in 116 patients. Br J Haematol 1994; 86: 754-760
12. Tollemar J, Hockerstedt K, Ericson BG, Jalanko H, Ringden O. Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized placebo-control study. Transplantation 1995; 59: 45-50
13. Burton JR, Zachery JB, Bessin R, Rathburn HK, Greenough WB III, Sterioff S, Wright JR, Slavin RE, Williams GM. Aspergillosis in four renal transplant recipients: Diagnosis and effective treatment with amphotericin H. Ann Intern Med 1972: 77: 383-388
14. Camarata PJ, Dunn DL, Farney AC. Partner RG, Selleskog EL. Continual intracavitary administration of amphotericin B as an adjunct in the treatment of Aspergillus brain abscess: Case report and review of the literature. Neurosurgery 1992; 31: 575-579
15. Coleman JM, Hogg GG, Rosenfeld JV. Waters KD. Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole and radical surgery - case report and review of the literature. Neurosurgery 1995; 36: 858-863